AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Agriculture, Rural Development, Food and Drug Administration, and related Agencies Appropriations seeking Food and Drug Administration funding. Discussion with the House and Senate on opioid addiction. Support for S. 2554, Patient Right to Know Drug Prices Act, which would ban "gag clauses" in contracts between all insurers and pharmacies. Support for H.R. 6, SUPPORT for Patients and Communities Act, a bill that addresses opioid addiction.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| JILLANNE SCHULTE | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PBM transparency. Support for H.R. 592/S. 109, Pharmacy and Medically Underserved Enhancement Act, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 4392, nullifying a rule finalized by the Centers for Medicare & Medicaid Services that modifies payment under Medicare for certain drugs purchased through the 340B discount program. Support for S. 2553, Know the Lowest Price Act of 2018, which would ban "gag clauses" in contracts between Part D plans and pharmacies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| JILLANNE SCHULTE | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with Congress on compounding. Communicated with House and Senate offices on drug shortages. Communication with DEA on opioid shortage of generic injectables. Support for S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2018, and H.R. 6142, Reducing Drug Waste Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| JILLANNE SCHULTE | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.